Updated on May 06, 2025 02:36:56 PM
Everything wouldn't seem possible in creation if there was no microbial intervention! The unsung microbial tale entails the powerhouse of innovation that accelerates economic prosperity nationwide. In India, the biotechnology sector is continuously maintaining and expanding its splendid position at a rapid growth rate worldwide. This network is the third largest biotechnology center in the Asia Pacific and ranks among top 12 destinations for biotechnology worldwide.
The Department of Biotechnology established BIRAC with the goal of fostering biotech entrepreneurship throughout the nation. Sustainable startups in India have made a cross-functional promotion of innovation in the field of biotechnology, enabling breakthroughs in furthering research.
The growing demand in this sector especially in India, placed a reliable focus after the covid-19 outbreak worldwide. Though this pandemic screwed up millions of lives, it has sharply surges the need for global research institutions that can procure adaptability and metabolism to fight against the deadliest virus.
Since the pandemic times had collapsed from health to wealth globally, it was India who has emerged as world leader to develop the world’s first DNA vaccine against the deadliest impact of COVID-19. Moreover, our biotechnology network has also designed, developed and supplied various vaccines for communicable diseases such as tetanus, measles and other mycobacterial infections.
With the variety of tools such as antivirals, gene therapies, molecular biology, and diagnostic tests have supplied its formula at every nook of the world, India is sharing around 3% of the global market which indicates the innovation driven technology that transforms the prudent idea in transporting realm of Indian progress and development to the world.
The biotechnology sector has been categorized into many intersecting fields such as— Biopharmaceuticals (62% ( $57.5 Bn), Bio agriculture (13% ( $11.5 Bn), Bio IT (10% ( $9.3 Bn) and Bio Services. These may contribute to building an innovative ecosystem in our country facilitating US$ 300 Bn by 2026. As per the data estimation, the Indian biotechnology industry is valued at 92 billion U.S. dollars in the year 2023 which has surpassed other rival countries behind. The FDI equity inflow stood at US$ 137 Bn according to DPIIT data estimation 2022-2023 and is expected to reach US$ 300 Bn by 2030.
To participate in FDI in the defense manufacturing sector, applicants are required to register under the Foreign Investment Facilitation Portal (FIFP). The procedure can be puzzling for any newcomer applicant since it incorporates several terms and conditions without rendering direct access to portals that can generate approvals for FDI.
Table of Content
The main objectives of FDI in biotechnology sector are listed below:
Following are the components permitted under FDI in Biotechnology Sector:
Note: Brownfield Pharma is allowed up to 74% through automatic route and above 74% through government route. 100% FDI is allowed under government route in this field.
Many documents are required for FDI in biotechnology sectors which are as follows:
Following are the procedures which required at the time of FDI in the biotechnology sector:
Applicants must fill out the online application form along with the relevant documents for making out the proposal for Foreign Direct Investment
Filing the proposal for FDI online within two working days, DIPP then will address the concerned administrative ministry to transfer the proposal of applicants electronically.
Collect all the requisite documents for continuing the process of the investment proposal. In case documents may be found incorrect, applicants will be held responsible in case of any deviation found.
The DIPP along with potential authorities will process the application internally and recognize various ministries for adding several comments such as the Ministry of Home Affairs, Reserve Bank of India, Ministry of External Affairs, Ministry Of Finances, etc.
There are conditions tapping for the procedure of FDI approval which must be understood by investors.
There are numerous significant valid reasons for investors that compel them to invest in FDI in India’s Biotechnology sector:
The benefits of FDI in biotechnology sector are listed below:
Conclusion
Foreign Direct Investment (FDI) in the Biotechnology sector has laid a quantum leap in the era of revolutionizing innovation powerhouse in the world. How microbial prowess can substantially change the blueprint for bringing out the bioeconomy at its pinnacle! To reduce the ineffective and puzzling formulation in finding solutions to the people’s problem, biotechnology ensures the smooth and quick solution to thought-provoking obstacles for the better health of the economy.
Several other factors to consider for investors while investing in science-driven industries sector are listed below:
Investors must also need to check eligibility criteria for buying investment in India in sectoral companies.
At Professional Utilities, we leverage our industry knowledge and expertise to help businesses navigate complex regulations, minimize risks, and optimize operations for maximum efficiency and profitability.
Frequently Asked Questions
The sectors within biotechnology that attract the most FDI are: Biopharmaceuticals, medical devices, genomics, agricultural biotechnology, and industrial biotechnology.
There are different types of FDI allowed in the biotechnology sector which includes: Mergers & Acquisitions, greenfield investments, joint ventures collaboration and minority stakes.
The current trends in FDI policies for biotechnology is to transfer, design and expand powerhouse of innovation and technology.
India is ranked among the 3rd largest biotech sector globally in terms of startups ecosystem and the largest vaccine manufacturers in the world.
Speak Directly to our Expert Today
Reliable
Affordable
Assured